Country: United States
Language: English
Source: NLM (National Library of Medicine)
TRAMADOL HYDROCHLORIDE (UNII: 9N7R477WCK) (TRAMADOL - UNII:39J1LGJ30J)
Janssen Pharmaceuticals, Inc.
TRAMADOL HYDROCHLORIDE
TRAMADOL HYDROCHLORIDE 300 mg
PRESCRIPTION DRUG
New Drug Application
ULTRAM ER- TRAMADOL HYDROCHLORIDE TABLET, EXTENDED RELEASE JANSSEN PHARMACEUTICALS, INC. ---------- HIGHLIGHTS OF PRESCRIBING INFORMATION THESE HIGHLIGHTS DO NOT INCLUDE ALL THE INFORMATION NEEDED TO USE ULTRAM ER SAFELY AND EFFECTIVELY. SEE FULL PRESCRIBING INFORMATION FOR ULTRAM ER. ULTRAM ER (TRAMADOL HYDROCHLORIDE) EXTENDED-RELEASE TABLETS FOR ORAL USE, C IV INITIAL U.S. APPROVAL: 1995 WARNING: ADDICTION, ABUSE, AND MISUSE; LIFE-THREATENING RESPIRATORY DEPRESSION; ACCIDENTAL INGESTION; ULTRA-RAPID METABOLISM OF TRAMADOL AND OTHER RISK FACTORS FOR LIFE-THREATENING RESPIRATORY DEPRESSION IN CHIDLREN; NEONATAL OPIOID WITHDRAWAL SYNDROME; INTERACTIONS WITH DRUGS AFFECTING CYTOCHROME P450 ISOENZYMES; AND RISKS FROM CONCOMITANT USE WITH BENZODIAZEPINES OR OTHER CNS DEPRESSANTS _SEE FULL PRESCRIBING INFORMATION FOR COMPLETE BOXED WARNING._ • • • • • • • RECENT MAJOR CHANGES INDICATIONS AND USAGE ULTRAM ER is an opioid agonist indicated for the management of pain severe enough to require daily around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. (1) ® ULTRAM ER EXPOSES USERS TO RISKS OF ADDICTION, ABUSE, AND MISUSE, WHICH CAN LEAD TO OVERDOSE AND DEATH. ASSESS PATIENT’S RISK BEFORE PRESCRIBING AND MONITOR REGULARLY FOR THESE BEHAVIORS AND CONDITIONS. (5.1) SERIOUS, LIFE-THREATENING, OR FATAL RESPIRATORY DEPRESSION MAY OCCUR. MONITOR CLOSELY, ESPECIALLY UPON INITIATION OR FOLLOWING A DOSE INCREASE. INSTRUCT PATIENTS TO SWALLOW ULTRAM ER TABLETS INTACT, AND NOT TO CUT, BREAK, CHEW, CRUSH, OR DISSOLVE THE TABLETS TO AVOID EXPOSURE TO A POTENTIALLY FATAL DOSE OF TRAMADOL. (5.2) ACCIDENTAL INGESTION OF ULTRAM ER, ESPECIALLY BY CHILDREN, CAN RESULT IN A FATAL OVERDOSE OF TRAMADOL. (5.2) LIFE-THREATENING RESPIRATORY DEPRESSION AND DEATH HAVE OCCURRED IN CHILDREN WHO RECEIVED TRAMADOL. SOME OF THE REPORTED CASES FOLLOWED TONSILLECTOMY AND/OR ADENOIDECTOMY; IN AT LEAST ONE CASE, THE CHILD HAD EVIDENCE OF BEING AN ULTRA-RAPID METABOLIZER OF TRAMADOL DUE TO A Read the complete document